This research program will explore - at a molecular and systems biology level - how “stemness” is maintained and how cardiac stem cell populations compromised by aging and disease might be rejuvenated. By better understanding the processes that underlie this phenomenon, and working in collaboration with biomaterials scientists, this consortium will advance the discovery of novel pharmaceuticals, bioengineered matrices, and cell-based therapies for heart disease.
Led by Professor Nadia Rosenthal
and Professor Richard Harvey
, this research program includes Australia’s leading experts in cardiac stem cells
from Monash University, Victor Chang Cardiac Research Institute, University of Queensland, University of New
South Wales and CSIRO.